What Are Peptides And Why Is Everyone Talking About Them?

Peptide therapies are being widely marketed for vitality and longevity.

Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might

Tonsil infections may be linked to other chronic inflammatory disorders, according to new study.

Pharmacy Has A Tower Records Problem. Outsiders Rebuilding The Tech Stack Might Help.

Tower Records was born in a drugstore. At its height, it had 200 locations and generated $1 billion in revenue in the late 90s. Then, in less than a decade, it was gone.

Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers

Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating radionuclide therapies.

Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies

Health insurer Centene reported first quarter net income of $1.5 billion despite a 2 million enrollee drop in Obamacare enrollment.

RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices

Examples of behavioral changes suggest the power of messaging when disseminated from a bully pulpit. Kennedy’s conspicuous visibility reinforces his reach.

Over A Million Annual Road Crash Deaths Prompt A New $350M Investment

Mike Bloomberg announced an additional $350 million commitment towards road safety against what’s been the leading cause of deaths worldwide for 5 to 29 year olds.

Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast

This article addresses the emerging use of adjuncts, such as 3D ultrasound, in breast cancer screening.

Large Study Looks At Benefits Of Doula Care On Postpartum Outcomes

A large study found specific benefits of a birth doula on maternal and newborn health outcomes.

TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling?

TrumpRx has signed deals with 86% of the branded drug market. But are prices actually falling for most Americans? A doctor takes a closer look at who benefits and what’s next.